Image

Triple EIT (Electrical Impedance Tomography)

Triple EIT (Electrical Impedance Tomography)

Recruiting
2-25 years
All
Phase N/A

Powered by AI

Overview

This study plans to learn more about ways to look at participant's lungs using new machines called Electrical Impedance Tomography (EIT). The EIT does not use harmful radiation like CT or x-ray. It is read through electrodes like using EKG reading heartbeats.

The investigators want to compare the results of patients who have chronic respiratory disease to patients without chronic respiratory disease to learn more about lung structure and composition.

Eligibility

Inclusion Criteria:

  • 2 weeks to 25 years of age
  • evidence of cardiopulmonary disease including, but not limited to:
    1. Post-prematurity respiratory disease
    2. Congenital diaphragmatic hernia
    3. Pulmonary Hypertension
    4. Congenital heart disease
    5. Respiratory failure
    6. Neuromuscular Disease
    7. Developmental or congenital lung disease

OR matched healthy controls (born at term gestation (\>36 weeks gestational age) with no cardiopulmonary disease)

Exclusion Criteria:

  • \<2 weeks of age
  • Anything that interferes with lead placement on the chest wall (such as, dermatologic conditions, multiple chest tubes, anatomic abnormality, or large dressings that cannot be moved)
  • No informed consent
  • Pregnant or lactating
  • Pacemaker or other metal intrathoracic surgical implant (causes noise in the data)

Study details
    Neonates and Preterm Infants
    Cardiopulmonary

NCT07247474

University of Colorado, Denver

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.